PMID- 16354539 OWN - NLM STAT- MEDLINE DCOM- 20060329 LR - 20061115 IS - 0161-6412 (Print) IS - 0161-6412 (Linking) VI - 27 IP - 8 DP - 2005 Dec TI - Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors. PG - 801-6 AB - OBJECTIVES: Angiogenesis is necessary for sustained neoplastic development. The angiopoietins Ang-1 and Ang-2 have been implicated in the regulation of this process; recent reports have suggested that a net gain in Ang-2 activity may be an initiating factor for tumor angiogenesis. We examined the recruitment of bone marrow-derived endothelial precursor cells into developing tumor neovasculature, and the spatial relationship between these cells and angiopoietin (Ang-1 and Ang-2) expression. METHODS: For this study T-cell depleted knockout mice (RAG-2/KO-5.2) were lethally irradiated and their bone marrow was reconstituted by bone marrow cells (BMCs) from transgenic mice (C57BL/Ka-Thy1.1) expressing green fluorescent protein (GFP). Rat glioma cells (RT-2/RAG) were then injected into the transplanted animals to form solid brain tumors. The animals were killed and their brains were analysed using immunohistochemistry and fluorescence-activated cell sorting. RESULTS: We found that BMCs migrated preferentially into the tumor when compared to adjacent healthy brain parenchyma. Furthermore, GFP+/CD34+ cells represented up to 8% of endothelial-like cells within the walls of tumor blood vessels. In the tumor, significant colocalization of Ang-2 with GFP+/CD34+ cells was noted (>80%), but colocalization with Ang-1 never exceeded 20%. In normal tissue directly surrounding the tumor, GFP+/CD34+ cells colocalized strongly with both angiopoietins (>75% and >70% for Ang-1 and Ang-2, respectively). DISCUSSION: The relative increase in angiopoietin-2 activity in brain tumors may result in the creation of a pro-angiogenic environment that enhances the recruitment of putative bone marrow-derived endothelial precursor cells into the tumor's developing vascular tree. FAU - Udani, V AU - Udani V AD - Department of Neurosurgery, Stanford University Medical Center, California, USA. vikudani@stanford.edu FAU - Santarelli, J AU - Santarelli J FAU - Yung, Y AU - Yung Y FAU - Cheshier, S AU - Cheshier S FAU - Andrews, A AU - Andrews A FAU - Kasad, Z AU - Kasad Z FAU - Tse, V AU - Tse V LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Neurol Res JT - Neurological research JID - 7905298 RN - 0 (Angiopoietin-1) RN - 0 (Angiopoietin-2) RN - 0 (DNA-Binding Proteins) RN - 0 (Neoplasm Proteins) RN - 0 (Rag2 protein, mouse) RN - 0 (Vascular Endothelial Growth Factor A) RN - 147336-22-9 (Green Fluorescent Proteins) SB - IM MH - Angiopoietin-1/biosynthesis/genetics/*physiology MH - Angiopoietin-2/biosynthesis/genetics/*physiology MH - Animals MH - Bone Marrow Cells/*physiology MH - Brain Neoplasms/*blood supply MH - Cell Line, Tumor/transplantation MH - Cell Lineage MH - Cell Movement/physiology MH - DNA-Binding Proteins/deficiency MH - Endothelial Cells/cytology MH - Endothelium, Vascular/*cytology MH - *Gene Expression Regulation, Neoplastic MH - Genes, Reporter MH - Glioma/*blood supply MH - Green Fluorescent Proteins/analysis/genetics MH - Hematopoietic Stem Cells/*physiology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Mice, Nude MH - Mice, SCID MH - Mice, Transgenic MH - Neoplasm Proteins/biosynthesis/genetics/*physiology MH - Neoplasm Transplantation MH - Neovascularization, Pathologic/*physiopathology MH - Radiation Chimera MH - Rats MH - Transplantation, Heterologous MH - Vascular Endothelial Growth Factor A/analysis EDAT- 2005/12/16 09:00 MHDA- 2006/03/30 09:00 CRDT- 2005/12/16 09:00 PHST- 2005/12/16 09:00 [pubmed] PHST- 2006/03/30 09:00 [medline] PHST- 2005/12/16 09:00 [entrez] AID - 10.1179/016164105X49319 [doi] PST - ppublish SO - Neurol Res. 2005 Dec;27(8):801-6. doi: 10.1179/016164105X49319.